Business Description
Defence Therapeutics Inc
NAICS : 325412
SIC : 3741
ISIN : CA24463V1013
Description
Financial Strength
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.23 | |||||
Equity-to-Asset | -3.43 | |||||
Debt-to-Equity | -0.66 | |||||
Debt-to-EBITDA | -0.13 | |||||
Piotroski F-Score | 1/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History |
---|
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 35.8 | |||||
9-Day RSI | 36.28 | |||||
14-Day RSI | 36.83 | |||||
6-1 Month Momentum % | -38.35 | |||||
12-1 Month Momentum % | -45.22 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.18 | |||||
Quick Ratio | 0.18 | |||||
Cash Ratio | 0.12 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | -7.66 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROA % | -810.52 | |||||
ROIC % | -2440.38 | |||||
ROC (Joel Greenblatt) % | -17639.54 | |||||
ROCE % | -3054.11 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
EV-to-EBIT | -4.99 | |||||
EV-to-EBITDA | -5 | |||||
EV-to-FCF | -14.47 | |||||
Earnings Yield (Greenblatt) % | -20.01 | |||||
FCF Yield % | -8.15 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Defence Therapeutics Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil C$) | |||
EPS (TTM) (C$) | -0.27 | ||
Beta | 0 | ||
Volatility % | 29.89 | ||
14-Day RSI | 36.83 | ||
14-Day ATR (C$) | 0.107591 | ||
20-Day SMA (C$) | 1.4465 | ||
12-1 Month Momentum % | -45.22 | ||
52-Week Range (C$) | 1.12 - 3.3 | ||
Shares Outstanding (Mil) | 45.44 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 1 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Defence Therapeutics Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Defence Therapeutics Inc Stock Events
Event | Date | Price(C$) | ||
---|---|---|---|---|
No Event Data |
Defence Therapeutics Inc Frequently Asked Questions
What is Defence Therapeutics Inc(XCNQ:DTC)'s stock price today?
When is next earnings date of Defence Therapeutics Inc(XCNQ:DTC)?
Does Defence Therapeutics Inc(XCNQ:DTC) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |